Current drug therapy--antiepilepsy agents.
D000927:Anticonvulsants / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D001463:Barbiturates / Q000627:therapeutic use; D055598:Chemical Phenomena; D002621:Chemistry; D004347:Drug Interactions; D004828:Epilepsies, Partial / Q000188:drug therapy; D004827:Epilepsy / Q000188:drug therapy*; D004832:Epilepsy, Absence / Q000188:drug therapy; D004833:Epilepsy, Temporal Lobe / Q000188:drug therapy; D004830:Epilepsy, Tonic-Clonic / Q000188:drug therapy; D006801:Humans; D006827:Hydantoins / Q000627:therapeutic use; D007408:Intestinal Absorption; D008862:Microsomes, Liver / Q000378:metabolism; D009044:Motor Cortex / Q000187:drug effects; D009207:Myoclonus / Q000188:drug therapy; D010113:Oxyphenbutazone / Q000494:pharmacology; D010672:Phenytoin / Q000494:pharmacology; D012877:Skin Manifestations; D013329:Structure-Activity Relationship; D013388:Succinimides / Q000627:therapeutic use
D000927:Anticonvulsants; D001463:Barbiturates; D006827:Hydantoins; D013388:Succinimides; D010672:Phenytoin; D010113:Oxyphenbutazone